The global Poultry Coccidiosis Vaccines market size is predicted to grow from US$ 127 million in 2025 to US$ 161 million in 2031; it is expected to grow at a CAGR of 4.0% from 2025 to 2031.

Poultry Coccidiosis Vaccines are specialized vaccines designed to prevent coccidiosis in poultry, a parasitic disease caused by protozoa such as Eimeria species that infect the intestinal tract of chickens, turkeys, and other poultry. These vaccines stimulate the immune system of poultry to develop resistance against coccidiosis, effectively reducing disease incidence and improving growth performance and feed conversion rates. Poultry coccidiosis vaccines are a crucial tool for controlling this disease and offer a safer and more environmentally friendly alternative to traditional anticoccidial drugs, with the added benefit of reducing the risk of drug resistance. They are widely used in modern intensive poultry farming.

United States market for Poultry Coccidiosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Poultry Coccidiosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Poultry Coccidiosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Poultry Coccidiosis Vaccines players cover MSD Animal Health, Boehringer Ingelheim, HIPRA, Bioproperties, Huvepharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the ?Poultry Coccidiosis Vaccines Industry Forecast? looks at past sales and reviews total world Poultry Coccidiosis Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Poultry Coccidiosis Vaccines sales for 2025 through 2031. With Poultry Coccidiosis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poultry Coccidiosis Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Poultry Coccidiosis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poultry Coccidiosis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Poultry Coccidiosis Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poultry Coccidiosis Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poultry Coccidiosis Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Poultry Coccidiosis Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Attenuated Vaccines
    Non-attenuated Vaccines

Segmentation by Application:

    Poultry
    Other Animals

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    MSD Animal Health
    Boehringer Ingelheim
    HIPRA
    Bioproperties
    Huvepharma
    Nisseiken
    Biopharm
    Ceva Sant Animale
    Vaxxinova
    Foshan Standard Biotech
    Qilu Qingda Bio-Pharmaceutical
    Skystar Bio-pharm
    Hlinte
    Guangdong Winsun Bio-pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Poultry Coccidiosis Vaccines market?
What factors are driving Poultry Coccidiosis Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Poultry Coccidiosis Vaccines market opportunities vary by end market size?
How does Poultry Coccidiosis Vaccines break out by Type, by Application?